Generics Bulletin Explains: The Next Wave Of US Humira Biosimilars
Start Of July Will See An Explosion Of Competition On Adalimumab In US From Eight Rivals
• By David Wallace
Eight further FDA-approved Humira biosimilars are set to launch • Source: Shutterstock 
